Company Name, Ticker, Competitors, else..

Timber Pharmaceuticals Inc (NYSE: TMBR)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Timber Pharmaceuticals Inc 's

Name: Timber Pharmaceuticals Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TMBR Sales vs. its Competitors Q2 2023

Comparing the current results to its competitors, Timber Pharmaceuticals Inc reported Revenue increase in the 2 quarter 2023 by 0 % year on year, while most of its competitors have experienced contraction in revenues by -9.66 %, achieved in the same quarter.

• List of TMBR Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Timber Pharmaceuticals Inc , slower than the average decrease reported by the company's competitors of -54.27 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -54.27 %

<< TMBR Stock Performance Comparisons

<< See the full list of TMBR competitors

*Market share is calculated based on total revenue.

TMBR's Stock Performance relative to its Competitors

Publicly Traded Peers of Timber Pharmaceuticals Inc

Os Therapies Incorporated
Share Performance

+25.75%

This Year

Os Therapies Incorporated

Profile

OS Therapies develops treatments for osteosarcoma and other solid tumors.

More about Os Therapies Incorporated's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 73.979 mill.	$ - mill.	$ -54.549 mill.

Prometheus Biosciences Inc
Share Performance

+0.47%

Over The Past 5 Days

Prometheus Biosciences Inc

Profile

Prometheus Biosciences Inc is a biotechnology company that operates on a subscription-based business model. Their platform offers personalized diagnostic tools and services to healthcare providers, enabling them to deliver targeted treatments for patients with gastrointestinal diseases. By providing ongoing support and monitoring, Prometheus aims to improve patient outcomes and revolutionize the management of chronic conditions in the field of gastroenterology.

More about Prometheus Biosciences Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 9,488.449 mill.	$ 3.995 mill.	$ -150.562 mill.

Sage Therapeutics Inc
Share Performance

+29.36%

This Quarter

Sage Therapeutics Inc

Profile

Sage Therapeutics Inc's business model primarily revolves around researching, developing, and commercializing innovative therapies for various central nervous system disorders. The company focuses on discovering novel molecules and applying them to create targeted treatments that address the unmet medical needs of patients. By harnessing scientific advancements and strategic collaborations, Sage aims to deliver transformative therapies for individuals suffering from conditions such as depression, postpartum depression, and other mood disorders.

More about Sage Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 543.460 mill.	$ 70.410 mill.	$ -301.195 mill.

Sangui Biotech International Inc
Share Performance

0.00%

Over The Past 5 Days

Sangui Biotech International Inc

Profile

Sangui Biotech International Inc's business model focuses on developing and commercializing innovative healthcare products. They aim to bring medical advancements and technological advancements together to improve patient care and outcomes. This is achieved through research, development, and the marketing of their healthcare solutions to various markets globally.

More about Sangui Biotech International Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.315 mill.	$ 0.081 mill.	$ -0.127 mill.

Acelyrin Inc
Share Performance

-0.22%

30 Days

Acelyrin Inc

Profile

Acelyrin Inc is a technology company that focuses on providing cutting-edge solutions in the healthcare industry. Their business model is centered around developing innovative software and hardware products that improve patient outcomes, enhance operational efficiency, and drive cost savings for healthcare organizations. By offering a range of advanced tools and services, Acelyrin Inc aims to revolutionize the healthcare sector and contribute to the overall advancement of digital health.

More about Acelyrin Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 228.544 mill.	$ - mill.	$ -268.517 mill.

109 more competitors available

Sources: Timber Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 11, 2026 9:45 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Timber Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.